Clinical Trials in Tennessee

Showing 15801-15820 of 20,239 trials

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

NCT02144051

This is a first time in man (FTIM), Phase I study to determine the Maximum Tolerated Dose, Recommended Phase 2 Dose, safety, tolerability and Pharmacokinetics of AZD5312. This is a multicentre study with sites in the United States and United Kingdom. Approximately 90 patients are expected to be enrolled in this study. The study involves two parts, Part A, Dose Escalation and Part B, Dose Expansion.

Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor

AstraZeneca32 participantsStarted May 2014

Sarasota, Florida, United States • Nashville, Tennessee, United States • Milwaukee, Wisconsin, United States +1 more locations

COMPLETEDPhase 2152 miles

Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

NCT00012220

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if gemcitabine is more effective when given alone or in combination with another chemotherapy drug in treating cancer of the pancreas. PURPOSE: Randomized phase II trial to compare the effectiveness of gemcitabine given alone or in combination with other chemotherapy drugs in treating patients who have metastatic cancer of the pancreas.

Pancreatic Cancer

Alliance for Clinical Trials in Oncology259 participantsStarted Jan 2001

Anniston, Alabama, United States • La Jolla, California, United States • San Diego, California, United States +73 more locations

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

Find Trials by Condition in Tennessee

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Capecitabine in Treating Patients With Malignant Mesothelioma

Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia

Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy

COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy

Paclitaxel in Treating Older Patients With Solid Tumors

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Clinical Evaluation of the AmniSure ROM Test

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

Irinotecan in Treating Patients With Advanced Cancer of the Stomach

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function